Larvol Cliniclarvol.hashnode.devยทSep 20, 2024Erlotinib and Proton Therapy for Locally Advanced Pancreatic Cancer: A Phase II TrialPurpose/Objective(s): Epidermal growth factor receptor (EGFR) is overexpressed in pancreatic cancer. EGFR expression plays a potentially important role in modulation of tumor sensitivity to either chemotherapy or radiotherapy. Erlotinib is a receptor...TumorAdd a thoughtful commentNo comments yetBe the first to start the conversation.
